Miho Miyagawa

Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation

Mayumi Ono, Akira Hirata, Takuro Kometani et al. · Molecular Cancer Therapeutics · 2004 · 309 citations · Full text

Medicine, Oncology, Pharmacology +17

Nanoparticle-Mediated Delivery of Nuclear Factor κB Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension

Satoshi Kimura, Kensuke Egashira, Ling Chen et al. · Hypertension · 2009 · 139 citations

Pharmacy, Pharmaceutics, Pharmacology +17

HER2 Overexpression Increases Sensitivity to Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, through Inhibition of HER2/HER3 Heterodimer Formation in Lung Cancer Cells

Akira Hirata, Fumihito Hosoi, Miho Miyagawa et al. · Cancer Research · 2005 · 110 citations

Medicine, Oncology, Pharmacology +16

Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension

Ling Chen, Kaku Nakano, Satoshi Kimura et al. · Hypertension · 2011 · 86 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Pitavastatin-Incorporated Nanoparticle-Eluting Stents Attenuate In-Stent Stenosis without Delayed Endothelial Healing Effects in a Porcine Coronary Artery Model

Noriaki Tsukie, Kaku Nakano, Tetsuya Matoba et al. · Journal of Atherosclerosis and Thrombosis · 2012 · 66 citations · Full text

Medicine, Cardiology, Pharmacology +17